Solutions Overview

ThumbPrint: Patient-Anchored Evidence

After a clinical trial closes, regulatory and commercial evidence needs don't stop — but tokenization-based approaches often can't keep up. Probabilistic matching and passive data linkage leave sponsors with cohort loss, coverage gaps, and no path to re-engage patients when post-trial questions arise.

See how a direct patient relationship established during the active trial preserves your full cohort for long-term follow-up (LTFU), post-marketing commitments (PMCs/PMRs), HEOR, and real-world evidence generation — with 0% cohort loss from identifier mismatches and 98% year-over-year patient retention.